Perspective Therapeutics, Inc.
CATX · AMEX · USD
$2.66
−0.05 −1.85%todayNot financial advice.
- Open
- 2.71
- Day range
- 2.63 - 2.76
- 52-week range
- 1.96 - 6.16
- Volume
- 1.1M
- Market cap
- 303.64M
- P/E ratio
- —
- EPS
- -1.33
- Dividend yield
- 0.00%
- Beta
- 0.4
Performance
W
−3.97%
1M
−13.36%
3M
−16.35%
6M
−40.63%
YTD
−3.27%
Y
−30.73%
5Y
−55.11%
All
−99.65%
In the news
Oct 8
FDA Grants Fast Track Designation to Perspective Therapeutics Cancer Drug PSV359
Perspective Therapeutics received FDA Fast Track designation for its cancer drug PSV359, which could speed up its development and review process.
Company news
Oct 8
Perspective Therapeutics Receives FDA Fast Track Status for Cancer Treatment PSV359
Perspective Therapeutics received FDA Fast Track designation for its cancer drug PSV359, which could speed up development and review.
Company news
Oct 8
FDA Grants Fast Track Designation to Perspective Therapeutics Cancer Treatment
Perspective Therapeutics received FDA Fast Track designation for its cancer therapy PSV359, sending its shares up over 4%.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/AMEX-CATX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Perspective Therapeutics, Inc. (CATX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/AMEX-CATX">CATX stock price</a> by FreeTheAI Stocks</p>